Published in Lancet on April 04, 1992
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. PLoS Med (2006) 3.83
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev (1996) 3.26
A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br J Clin Pharmacol (1998) 1.82
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother (2001) 1.53
Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob Agents Chemother (1999) 1.27
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Bull World Health Organ (1994) 1.25
Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children. Malar J (2007) 1.23
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon. Antimicrob Agents Chemother (2003) 1.18
Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria. Antimicrob Agents Chemother (1999) 1.15
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health (2003) 1.04
Neurotoxicity of artemisinin analogs in vitro. Antimicrob Agents Chemother (1994) 1.02
Mefloquine. BMJ (1994) 0.98
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria. Br J Clin Pharmacol (2002) 0.89
N-acetylcysteine in severe falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health (2003) 0.88
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand. Southeast Asian J Trop Med Public Health (2003) 0.87
Chemotherapy of drug-resistant malaria. Can J Infect Dis (1996) 0.83
Antimalarial activity of WR 243251, a Dihydroacridinedione. Antimicrob Agents Chemother (1994) 0.83
Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non-severe falciparum malaria in Myanmar. Bull World Health Organ (1998) 0.82
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients. PLoS One (2017) 0.81
Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007. Malar J (2012) 0.77
Management of malaria in Thailand. Korean J Parasitol (2002) 0.75
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A (2000) 10.27
Haplotype variation and linkage disequilibrium in 313 human genes. Science (2001) 8.52
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage (1997) 5.98
Contribution of a general-practitioner hospital. Br Med J (1971) 4.73
Needle fixation, the drug user's perspective: a qualitative study. Addiction (2001) 4.41
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis (2009) 4.19
Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J Bacteriol (1996) 3.98
Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother (2000) 3.46
Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg (1996) 3.36
Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg (1999) 2.98
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg (2000) 2.76
High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet (1987) 2.52
Paclitaxel administration to gynecologic cancer patients with major cardiac risk factors. J Clin Oncol (1998) 2.45
Urodynamic variables cannot be used to classify the severity of detrusor instability. Br J Urol (1998) 2.36
Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma. Trans R Soc Trop Med Hyg (1997) 2.33
Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor. Lancet (1973) 2.25
The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther (1970) 2.23
Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry (1998) 2.12
Management of premature rupture of membranes at term: randomized trial. Am J Obstet Gynecol (1994) 2.08
Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J Trop Med Public Health (1991) 2.06
Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol (2001) 2.05
Neisseria gonorrhoeae strains isolated in Hong Kong: in vitro susceptibility to 13 antibiotics. Antimicrob Agents Chemother (1981) 1.98
Penicillinase-producing Neisseria gonorrhoeae isolates from different localities in south east Asia. Susceptibility to 15 antibiotics. Br J Vener Dis (1983) 1.96
Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg (1994) 1.93
Chloroquine-resistant falciparum malaria in Thailand. Lancet (1965) 1.89
Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol (1999) 1.87
Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis (1993) 1.85
Antimalarial activity of mefloquine and qinghaosu. Lancet (1982) 1.81
Water permeability of polyunsaturated lipid membranes measured by 17O NMR. Biophys J (1997) 1.79
Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal Biochem (2001) 1.65
Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis (1995) 1.65
Qualitative and semiquantitative polymerase chain reaction to predict Plasmodium falciparum treatment failure. J Infect Dis (1994) 1.61
Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1997) 1.60
Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J Clin Invest (1998) 1.59
Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis (1994) 1.57
Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity. Gynecol Oncol (1996) 1.57
Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob Agents Chemother (2000) 1.52
Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med (1978) 1.52
Sulphormethoxine in chloroquine-resistant falciparum malaria in Thailand. Lancet (1967) 1.49
A method for noninvasive determination of inspiratory resistance during proportional assist ventilation. Am J Respir Crit Care Med (2001) 1.48
Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet (1992) 1.46
Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci (1998) 1.46
Role of meningococcal endotoxin in meningococcal purpura. J Exp Med (1974) 1.45
Links between anaesthetic modality and nerve damage during lower third molar surgery. Br Dent J (2002) 1.44
Serum CA-125 measurements > 65 U/mL. Clinical value. J Reprod Med (1997) 1.44
Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann Trop Med Parasitol (1999) 1.44
Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organ (1995) 1.43
Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg (1993) 1.43
Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. Antimicrob Agents Chemother (1993) 1.43
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet (1984) 1.42
Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial. Med Care (2001) 1.41
Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults. Infect Immun (1989) 1.41
EMG biofeedback assisted KT-1000 evaluation of anterior tibial displacement. Knee Surg Sports Traumatol Arthrosc (2000) 1.40
Measuring the impact of intimate partner violence on the health of women in Victoria, Australia. Bull World Health Organ (2006) 1.40
Chitinases in trypanosomatidae: a cautionary note. Parasitol Today (1992) 1.39
Opisthorchiasis and intestinal fluke infections in northern Thailand. Southeast Asian J Trop Med Public Health (1998) 1.37
Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Public Health (1991) 1.37
Pulmonary oedema in vivax malaria. Trans R Soc Trop Med Hyg (1998) 1.36
Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species. Anal Biochem (2001) 1.36
Liquefaction of Autographa californica nucleopolyhedrovirus-infected insects is dependent on the integrity of virus-encoded chitinase and cathepsin genes. Virology (1997) 1.34
Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res (2004) 1.34
Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol (1987) 1.34
Mental illness and help-seeking behavior among Mariel Cuban and Haitian refugees in south Florida. J Health Soc Behav (1992) 1.32
A study of the factors affecting the metabolic clearance of quinine in malaria. Eur J Clin Pharmacol (1997) 1.28
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. Am J Trop Med Hyg (1999) 1.28
Possible medication errors in home healthcare patients. J Am Geriatr Soc (2001) 1.27
Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand. Southeast Asian J Trop Med Public Health (2001) 1.27
Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis (1995) 1.26
Yersinia pestis infection in Vietnam. II. Quantiative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis (1976) 1.26
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis (1999) 1.26
Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am J Trop Med Hyg (1996) 1.26
Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria? Southeast Asian J Trop Med Public Health (2001) 1.25
Hidden Plasmodium falciparum infections. Southeast Asian J Trop Med Public Health (1999) 1.25
Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. Br Med J (Clin Res Ed) (1986) 1.24
The dielectric properties of aqueous solutions of poly(ethylene glycol) and their influence on membrane structure. Biochim Biophys Acta (1985) 1.23
In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904. Antimicrob Agents Chemother (1981) 1.23
Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens. Am J Trop Med Hyg (1996) 1.23
Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and (31)P-NMR. J Lipid Res (2001) 1.22
Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast Asian J Trop Med Public Health (1991) 1.21
Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: A methodological approach. Anal Biochem (1999) 1.21
In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics. Antimicrob Agents Chemother (1981) 1.21
Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J Infect Dis (1998) 1.20
An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health (2005) 1.20
Dynamics of membrane penetration of the fluorescent 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) group attached to an acyl chain of phosphatidylcholine. Biophys J (2001) 1.19
Liver profile changes and complications in jaundiced patients with falciparum malaria. Trop Med Parasitol (1994) 1.18
Pulmonary edema in cerebral malaria patients in Thailand. Southeast Asian J Trop Med Public Health (1998) 1.18
A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg (1999) 1.18
Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet (1985) 1.18
Development and validation of flow cytometric measurement for parasitaemia using autofluorescence and YOYO-1 in rodent malaria. Parasitology (2007) 1.18